Logo image of NAKA

KINDLY MD INC (NAKA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NAKA - US49457M1062 - Common Stock

0.4568 USD
-0.03 (-5.56%)
Last: 1/16/2026, 8:00:01 PM
0.461 USD
+0 (+0.92%)
After Hours: 1/16/2026, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NAKA. NAKA was compared to 102 industry peers in the Health Care Providers & Services industry. NAKA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, NAKA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NAKA had negative earnings in the past year.
  • In the past year NAKA has reported a negative cash flow from operations.
NAKA Yearly Net Income VS EBIT VS OCF VS FCFNAKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

  • With a Return On Assets value of -13.07%, NAKA is not doing good in the industry: 75.49% of the companies in the same industry are doing better.
  • NAKA has a Return On Equity of -18.95%. This is in the lower half of the industry: NAKA underperforms 62.75% of its industry peers.
Industry RankSector Rank
ROA -13.07%
ROE -18.95%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAKA Yearly ROA, ROE, ROICNAKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

  • NAKA has a Gross Margin of 98.85%. This is amongst the best in the industry. NAKA outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of NAKA has remained more or less at the same level.
  • NAKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
NAKA Yearly Profit, Operating, Gross MarginsNAKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

  • NAKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NAKA has more shares outstanding
  • Compared to 1 year ago, NAKA has an improved debt to assets ratio.
NAKA Yearly Shares OutstandingNAKA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
NAKA Yearly Total Debt VS Total AssetsNAKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • NAKA has an Altman-Z score of -0.03. This is a bad value and indicates that NAKA is not financially healthy and even has some risk of bankruptcy.
  • NAKA has a Altman-Z score of -0.03. This is in the lower half of the industry: NAKA underperforms 78.43% of its industry peers.
  • There is no outstanding debt for NAKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.03
ROIC/WACCN/A
WACC8.92%
NAKA Yearly LT Debt VS Equity VS FCFNAKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

  • NAKA has a Current Ratio of 0.13. This is a bad value and indicates that NAKA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of NAKA (0.13) is worse than 93.14% of its industry peers.
  • A Quick Ratio of 0.13 indicates that NAKA may have some problems paying its short term obligations.
  • The Quick ratio of NAKA (0.13) is worse than 93.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
NAKA Yearly Current Assets VS Current LiabilitesNAKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

5

3. Growth

3.1 Past

  • NAKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.31%.
  • NAKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.13%.
  • Measured over the past years, NAKA shows a small growth in Revenue. The Revenue has been growing by 2.79% on average per year.
EPS 1Y (TTM)-103.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.3%
Revenue 1Y (TTM)-31.13%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-40.08%

3.2 Future

  • Based on estimates for the next years, NAKA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.35% on average per year.
  • The Revenue is expected to grow by 215.68% on average over the next years. This is a very strong growth
EPS Next Y52.12%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue Next Year-33.16%
Revenue Next 2Y228.8%
Revenue Next 3Y215.68%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NAKA Yearly Revenue VS EstimatesNAKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
NAKA Yearly EPS VS EstimatesNAKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NAKA. In the last year negative earnings were reported.
  • Also next year NAKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAKA Price Earnings VS Forward Price EarningsNAKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAKA Per share dataNAKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NAKA's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.15%
EPS Next 3Y25.35%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for NAKA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KINDLY MD INC

NASDAQ:NAKA (1/16/2026, 8:00:01 PM)

After market: 0.461 +0 (+0.92%)

0.4568

-0.03 (-5.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-19
Earnings (Next)03-26
Inst Owners24.99%
Inst Owner ChangeN/A
Ins Owners6.28%
Ins Owner Change81.52%
Market Cap200.92M
Revenue(TTM)1.98M
Net Income(TTM)-90.49M
Analysts82.5
Price Target1.27 (178.02%)
Short Float %5.13%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-84.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-425%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 101.46
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS1.09
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.07%
ROE -18.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.85%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93921.5%
Cap/Sales 34432.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -0.03
F-Score4
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.3%
EPS Next Y52.12%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.13%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-40.08%
Revenue Next Year-33.16%
Revenue Next 2Y228.8%
Revenue Next 3Y215.68%
Revenue Next 5YN/A
EBIT growth 1Y-465.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-394.94%
EBIT Next 3Y84%
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A

KINDLY MD INC / NAKA FAQ

What is the ChartMill fundamental rating of KINDLY MD INC (NAKA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NAKA.


What is the valuation status for NAKA stock?

ChartMill assigns a valuation rating of 1 / 10 to KINDLY MD INC (NAKA). This can be considered as Overvalued.


How profitable is KINDLY MD INC (NAKA) stock?

KINDLY MD INC (NAKA) has a profitability rating of 1 / 10.